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Abstract 
Changes in the expression of estrogen-related substances in 
monkeys’ brains at the menopausal transition, when estrogen deficit starts 
to occur, have not yet been examined thoroughly. In the present study, we 
immunohistochemically investigated the expression levels of estrogen 
receptor beta (ERβ) and aromatase (local estrogen synthesizing enzyme) in 
the hippocampal formation of premenopausal, menopausal, and 
ovariectomized premenoposal monkeys. In all monkeys tested, ERβ 
immunoreactivity was observed in interneurons located in the subiculum 
and the Ammon’s horn, and most of these ERβ-immunoreactive neurons 
coexpressed a GABAergic neuron marker, parvalbumin. In the menopausal 
monkeys who exhibited a decline in estrogen concentration, hippocampal 
ERβ was highly upregulated, while aromatase expression was not 
markedly changed. By contrast, aromatase in the ovariectomized monkeys 
was significantly upregulated, while ERβ expression was not changed. In 
the brains of ovariectomized and menopausal monkeys, depletion of 
ovary-derived estrogen brought about different reactions which may be 
attributed to the senescence of brain aging.  
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1. Introduction 
Estrogen homeostatically keeps exerting influences on the brain, as 
well as on peripheral organs, at regular cycles over almost half of women’s 
life until menopause. A relationship between estrogen and cognitive 
functions has been clinically documented indicating that menopausal 
women are at a higher risk of developing Alzheimer’s disease (AD) and 
depression (Launer et al., 1999; Weissman et al., 1993) although there 
remains some controversy over the sex difference (Hebert et al., 2001). The 
aged hippocampus is particularly vulnerable to age-related 
neurodegenerative disorders presenting as atrophy (De Leon et al., 1997), 
increased levels of neurofilament protein (Vickers et al., 1994), senile 
plaques and neurofibrillary tangles (Hof, 1997; Rapp et al., 2006), and 
synapse loss (West et al., 1994). The neural circuits between the 
hippocampus and the neocortex are highly degenerated in AD patients 
whose episodic memory is often affected even at an early stage of AD 
(Morrison and Hof, 1997). Studies of aged monkeys have demonstrated 
that age-related cognitive impairment reflects the vulnerability of these 
circuits and that the synaptic alterations occurring in pyramidal cells can 
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be restored by estrogen administration (Hof, 1997). Although the estrogen 
replacement therapy (ERT) for menopausal women is expected to have 
protective effects on the prefrontal cortex and the hippocampus to protect 
against AD-related cognitive declines (Gibbs and Aggarwal, 1998), there is 
thought to be a critical window for the initiation of ERT (Henderson et al., 
2003). The menopausal transition, a limited period following the loss of 
ovary function, is considered to be highly susceptible to hormone treatment 
(Gibbs and Gabor, 2003). Macaques, including Japanese monkeys and 
rhesus monkeys, enter menopause at around 25 years old, and have a 
postreproductive life span of 5 or more years (Pavelka and Fedigan, 1999; 
Walker, 1995). Aged monkeys can be an appropriate model in terms of 
sharing similar endocrinological and histological senescence of the ovary 
with humans (Gilardi et al., 1997; Nichols et al., 2005; Nozaki et al., 1995).  
In broad areas of the brain, estradiol binds almost equally to two 
different subtypes of estrogen receptors, ERα and ERβ (Kuiper et al., 1997). 
Previous studies have demonstrated that ERβ mRNA (Gundlah et al., 
2000) and protein (Blurton-Jones et al., 1999) were more abundant than 
those of ERα in the monkey hippocampus. Selective ERβ agonists enhance 
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synaptic plasticity in the hippocampus and cognitive performance, which 
was confirmed by absence of the effects in ERβ knockout mice (Liu et al., 
2008; Walf et al., 2008). ERβ is suggested to colocalize with GABAergic 
neuron marker, parvalbumin and indirectly upregulate brain-derived 
neurotrophic factor in the rat (Blurton-Jones and Tuszynski, 2002; 2006). 
However, the primate hippocampus has not been analyzed in terms of 
colocalization of ERβ and GABAergic neuron markers, such as calcium 
binding proteins.  
Estrogen is derived not only from endocrine glands, but also from the 
brain. Aromatase contributes to the conversion of androgens into estrogens, 
the last step of estrogen synthesis. Previous immunohistochemical studies 
have shown the presence of de novo synthesized neurosteroids in the 
monkey (Wehrenberg et al., 2001; Yague et al., 2008) and human (Webber 
et al., 2006; Yague et al., 2010) hippocampus. In order to study 
menopause-related changes in the brain, it is necessary to consider local 
estrogen synthesis in the brains of young and aged females, whose 
peripheral hormone levels are utterly different. In the present study, we 
attempted to elucidate the changes of ERβ and aromatase expression in the 
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monkey hippocampus under the diminished blood levels of estrogen which 
were caused by natural menopause and surgical ovariectomy.  
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2. Materials and methods 
 
2.1 Animals 
Twelve female Japanese monkeys (Macaca fuscata) used in this 
study were housed individually in indoor cages. Based on the age and 
daily menstruation records, nine monkeys were assigned to one of three 
categories: premenopausal (n=3; age 9 yr, 11 yr and 13 yr; regular monthly 
menstruation), perimenopausal (n=3; age 25, 26 and 26 yr; irregular 
menstruation within past 1 year), and postmenopausal (n=3; aged 29, 30 
and 31 yr; no episodes of menstrual bleeding for at least 2 years). The 
cycling premenopausal monkeys were sacrificed on the second day (D2) 
(monkey ID, Mff1538 and Mff1564) or D5 (monkey ID, Mff1729) of menses 
(i.e. in the early follicular phase). The remaining three premenopausal 
monkeys were bilaterally ovariectomized (n=3; age 9, 13 and 18 yr; regular 
monthly menstruation) on D20 (monkey ID, Mff1512) or D24 (monkey ID, 
Mff1283 and Mff1736) of menses (i.e. in the luteal phase). Then, they were 
sacrificed two months after the operation, as a perimenopausal model in 
endocrinological aspects. To verify circulating hormone levels of all 
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monkeys, blood samples at the point of sacrifice were assayed for 
17β-estradiol, progesterone and luteinizing hormone (LH). Additionally, in 
several premenopausal, perimenopausal and ovariectomized monkeys, the 
hormonal rhythmicity was monitored by analyzing blood samples collected 
every 2 - 3 days during more than 120 days. All animals were pretreated 
with 10 mg/kg ketamine hydrochloride (Sankyo Yell Yakuhin Co., Ltd., 
Tokyo, Japan) and deeply anesthetized with 30 mg/kg pentobarbital 
sodium (Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan). Monkeys 
were perfused through the heart with the prewash solution, and then 
perfused with 4% paraformaldehyde. After perfusion, the brains were 
immediately removed and then immersed in 2% PFA and 5% sucrose in 
phosphate-buffered saline (PBS) for 24 hours, followed by successive 
immersions in 10%, 20% and 30% sucrose in PBS. The brain blocks cut into 
the coronal plane at 5-mm thickness were embedded in Tissue-Tek OCT 
compound (Miles Inc, Elkhart, IN, USA) followed by rapid freezing in a 
dry-ice acetone bath. All experimental procedures were planned and 
executed in accordance with The Guide for the Care and Use of Laboratory 
Primates (2002) established by the Primate Research Institute of Kyoto 
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University and NIH Guide for the Care and Use of Laboratory Animals 
(1996). 
 
2.2 Measurement of hormone levels by radioimmunoassay (RIA)  
The blood samples were analyzed for LH levels using a heterologous 
RIA system described previously (Watanabe et al., 1990). The iodinated 
preparation was NIDDK-rat LH-I-5. The antiserum was anti-ovine LH 
(YM#18; Dr. Y. Mori, University of Tokyo, Tokyo, Japan). Concentrations 
of 17β-estradiol and progesterone were measured using double-antibody 
RIA systems with 125I-labeled radioligands, as previously described (Taya 
et al., 1985) using antiserum against 17β-estradiol (GDN#244; Dr. G. D. 
Niswender, Animal Production and Biotechnology, Colorado State 
University, Fort Collins, CO, USA) and against progesterone (GDN#337; 
Dr. G. D. Niswender, Animal Production and Biotechnology, Colorado 
State University, Fort Collins, CO, USA). The intra- and interassay 
coefficients of variation were 4.4% and 16.1% for LH, 4.7% and 13.3% for 
17β-estradiol, and 5.5% and 16.8% for progesterone, respectively.  
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2.3 Immunohistochemistry 
The coronal sections were cut at 40-μm thickness with a cryostat 
(HM500-M, Micron, Waldorf, Germany) and stored in cryoprotectant at 
-20°C until the time of processing (Watson et al., 1986). 
Immunohistochemistry of monkey brains was performed as described 
elsewhere (Hayashi et al., 2001). The sections were washed in PBS, 
processed with additional antigen retrieval by boiling for 30 min in citrate 
buffer (pH 6.8) for anti-aromatase staining, and then soaked in 0.3% H2O2 
in methanol for 30 min to inactivate endogenous peroxidase. They were 
preincubated with PBS containing 0.5% TritonX-100, 4% goat or donkey 
serum and 10% fish gelatin for 1 h at room temperature. 
For the single-label staining, the sections were incubated with 
antibody against human ERβ (N-19, 1:50, Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA), or human placental aromatase (R-8-1, 1:1000, 
generously supplied by Dr. Y. Osawa) for 48 h at 4°C. The specificities of 
these antibodies were shown in the following studies: ERβ (Kruijver et al., 
2003) and aromatase (Ishimura et al., 1989) antibodies. After brief washes 
with PBS, sections were treated with a biotinylated second antibody for 24 
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h at 4°C, and then processed with the avidin-biotin complex peroxidase 
method (ABC elite kit, Vector Laboratories, Burlingame, CA, USA). The 
immunoreactive sites were visualized with a solution of 0.003% H2O2, 0.6 
mg/ml 3, 3’-diaminobenzidine tetrahydrochloride (DAB-buffer tablets, 
Merck, Darmstadt, Germany). The adjacent sections were stained by the 
Nissl-staining method with cresyl violet (Merck, Darmstadt, Germany) for 
cytoarchitectonic reference.  
For the double-label immunofluorescence to identify colocalization of 
ERβ with one of the calcium binding proteins, parvalbumin (PV) , 
calretinin (CR) or calbindin (CB), ERβ immunoreactivity was detected 
using a tyramide signal amplification kit (TSA Perkin Elmer, Boston, MA, 
USA) after endogenous peroxidase activity was reduced with 3% H2O2 in 
PBS for 30 min. Then, the sections were incubated with diluted antibody 
for PV (clone PARV-19, 1:2000, Sigma, Saint Louis, MO, USA), CR (clone 
6B3, 1:2000, Swant, Bellinzona, Switzerland) or CB (clone 300, 1:2000, 
Swant, Bellinzona, Switzerland) for 48 h at 4°C and immunoreactivities 
were visualized with second antibody conjugated to AlexaFluor-546 (1:200, 
Molecular Probes, Eugene, OR, USA). Immunolabeled images were directly 
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captured by an Olympus BX-50 fluorescence microscope connected to a 
digital camera Olympus DP20 (Olympus Corporation, Tokyo, Japan). 
Confocal images were obtained with a LSM5 Pascal laser-scanning 
microscope (Carl Zeiss, Jena, Germany). 
 
2.4 Semi-quantitative image analysis 
The degree of immunoreactivity for ERβ and aromatase in the 
subiculum was expressed as the integrated optical density (IOD; the 
product of optical density and area) by using computer-assisted image 
analysis (NIH ImageJ; http://rsb.info.nih.gov/nih-image/). We identified the 
subiculum from adjacent Nissl-stained images. The specified subicular 
region on the gray scale image stained for ERβ was processed with 
thresholding filter (maximum entropy) to select ERβ-immunostained pixels 
for IOD calculation. The number of ERβ-immunoreactive cells was also 
counted manually in each subicular region. These analyses for ERβ were 
performed in five sections of each animal. For the aromatase 
immunoreactivity, two different fields from a section, three sections from 
each animal, including pyramidal neurons homogeneously in the 
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subiculum were analyzed. Unlike ERβ immunoreactivity, aromatase 
immunoreactivity showed uniform cellular and subcellular localization in 
all the four monkey groups. In order to precisely evaluate the intensity of 
aromatase immunostaining in individual cells, 30 pyramidal cells with 
relatively large cross-section (minor axis length of the soma > 9 μm) were 
selected in a field and delineated manually. The mean IOD value of the 
selected cells in an image was calculated. ERβ-immunoreactive neurons 
colocalizing with PV were counted manually in two different fields within 
the merged fluoroscopic subiculum area. The analysis for ERβ/PV 
colocalization was performed in three sections of each animal. All results 
were statistically analyzed with one-way analysis of variance followed by 
the Games-Howell test for multiple comparisons. Differences were 
considered statistically significant if the p value was less than 0.05.  




3.1 Hormonal profile at each reproductive stage 
The premenopausal monkeys exhibited regular menstruation and 
estrogen, progesterone and LH surges until they were sacrificed (Fig. 1). In 
ovariectomized monkeys, the mean circulating estrogen level dropped 
drastically to below one-sixth the pre-ovariectomy level within 4 days and 
the LH level became elevated to over six-fold within 8 days after the 
operation. Like the ovariectomized monkeys at postoperation, the 
perimenopausal monkeys exhibited low estrogen and high LH levels with 
no menstrual bleeding, in spite of having shown irregular menstruation 
during the previous year. Individual endocrine backgrounds at the time of 
sacrifice confirmed the reproductive stage of each monkey. 
 
3.2 ERβ and aromatase immunoreactivity localizations  
We found conspicuous ERβ immunoreactivity in the hippocampal 
formation of all monkey groups (Fig. 2a). Within the hippocampal 
formation, ERβ was confined to the plasma membrane and perikaryon, but 
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not to the nucleus. Membranous ERβ immunoreactivity was most intensely 
observed throughout the subiculum (Fig. 2c). These subicular 
ERβ-immunoreactive neurons were found to consist of interneurons of 
fusiform or multipolar type that could be distinguished from typical 
pyramidal neurons. In addition, ERβ-immunoreactive neurons were 
located in the stratum oriens of the Ammon’s horn (Fig. 2e). To 
characterize these ERβ-immunoreactive neurons, double 
immunofluorescence histochemistry was carried out for calcium-binding 
proteins: PV, CR and CB. A large population of ERβ-immunoreactive 
neurons exhibited PV immunoreactivity in the hippocampal formation (Fig. 
3a, b). Within the subiculum, approximately 70 to 85% of the total 
ERβ-immunoreactive neurons were co-localized with PV in each of the 
premenopausal, ovariectomized, perimenopausal and postmenopausal 
monkey groups, and about 75 to 80% of the total PV-immunoreactive 
neurons were co-localized with ERβ. Throughout the hippocampal 
formation, no ERβ-immunoreactivity was found to be co-localized with CR 
or CB in a cell (Fig. 3c, d).  
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The immunoreactivity of aromatase, the enzyme responsible for local 
estrogen biosynthesis, was present homogeneously in pyramidal neurons 
and interneurons extending from Ammon’s horn to the subiculum (Fig. 2b, 
d, f).  
 
3.3 Menopause-related changes in ERβ and aromatase immunoreactivities 
In the ovariectomized monkeys, our quantitative analysis showed 
that the intensity of ERβ immunoreactivity was similar to that in the 
premenopausal group (Fig.4a). In the premenopausal and ovariectomized 
monkeys, ERβ immunoreactivity was localized primarily in somatic 
membrane sites and, to a lesser extent, in proximal dendrites. By contrast, 
the intensity of aromatase immunoreactivity in the subiculum was 
significantly higher in the ovariectomized monkeys than in the 
premenopausal monkeys (p < 0.01, Fig. 4b). Upregulation after 
ovariectomy and a lack of age-dependent change in aromatase expression 
were also observed in other subregions of the hippocampus, such as CA1.  
In both the perimenopausal and postmenopausal monkeys, on the 
other hand, the ERβ levels were highly elevated as compared to those in 
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the premenopausal monkeys (p < 0.05, Fig. 4a). The number of 
ERβ-immunoreactive neurons, however, was not altered with menopause 
(the mean cell number ± standard error per mm2 subicular area, 
premenopausal: 365.5 ± 19.0, ovariectomized: 338.6 ± 18.6, 
perimenopausal: 362.5 ± 21.9, postmenopausal: 345.0 ± 13.9; one-way 
analysis of variance, p = 0.708). Upregulation of ERβ immunoreactivity of 
subicular interneurons in perimenopausal and postmenopausal monkeys 
was observed in somatic membranes and dendrites (both proximal and 
distal) compared with that in premenopausal monkeys. Meanwhile, 
aromatase immunoreactivity in the subiculum of the perimenopausal and 
the postmenopausal monkeys was similar to that of the premenopausal 
monkeys (Fig. 4b). Size of aromatase immunoreactive soma in the 
postmenopausal monkeys was significantly smaller than that of 
premenopausal and ovariectomized monkeys (the mean soma sizes ± 
standard error (μm2), premenopausal: 183.81 ± 4.59, ovariectomized: 
194.57 ± 4.24, perimenopausal: 184.01 ± 5.53, postmenopausal: 167.00 ± 
3.13).   
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4. Discussion 
Here we report that ERβ expression is prominent in the subiculum of 
the hippocampal formation of menopausal monkeys. In the present study, 
ERβ immunoreactivity in the hippocampus was identified at the plasma 
membrane of non-pyramidal neurons. The estrogen receptors are 
classically well known to exert genomic actions through translocation into 
the cell nucleus from the cytoplasm when they bind to 17β-estradiol 
(McKenna and O'Malley, 2002). Both ERα and ERβ also exert non-genomic 
rapid action to regulate cell signaling pathways, including calcium ion 
channels and kinase signaling pathways (Raz et al., 2008). ERβ expression 
at the plasma membrane has been convincingly confirmed by electron 
microscopy and time lapse microscopy (Milner et al., 2005; Sheldahl et al., 
2008). Rapid action of membranous ERβ was confirmed with the study 
using membrane-impermeable estradiol conjugated to bovine serum 
albumin and selective ERβ agonist (Wu et al., 2011). Such rapid action may 
be exerted in the monkey hippocampus. 
Our finding that many of the ERβ-immunoreactive neurons 
co-expressed PV in the subiculum of monkey hippocampal formation was 
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consistent with the study in the rat (Blurton-Jones and Tuszynski, 2002). 
It has been well-known that estrogen affects the mRNA expression of a 
GABA transporter and a GABA-synthesizing enzyme, glutamic acid 
decarboxylase (Herbison et al., 1995; McCarthy et al., 1995). In the CA1 of 
hippocampus, estrogen reduces GABA synthesis in inhibitory interneurons 
that regulates pyramidal neurons (Murphy et al., 1998). Our study 
suggests that ERβ is concerned with regulation of GABAergic systems in 
the subiculum, which sends excitatory output signals from the 
hippocampus to widespread areas.    
Aromatase localized in hippocampal neurons synthesize 
17β-estradiol (Hojo et al., 2004). Aromatase expression in the hippocampus 
is confirmed immunohistochemically in both cycling and ovariectomized 
monkeys (Yague et al., 2008) and in menopausal humans (Ishunina et al., 
2007). We confirmed aromatase expression in all groups examined. 
Our study showed that ovariectomized monkeys retained an ERβ 
level in the subiculum equivalent to that of premenopausal monkeys. 
Alternately, immunoreactivity for aromatase was upregulated in the 
subiculum of ovariectomized monkeys. In contrast to ovariectomized 
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monkeys, perimenopausal and postmenopausal monkeys exhibited obvious 
upregulation of ERβ with unaltered aromatase expression in the subiculum 
of hippocampal formation. Though both ovariectomized and menopausal 
monkeys experienced peripheral estrogen depletion, reactive regulation in 
the expression of aromatase and ERβ was quite different. Though 
difference in the senescence of the brain may cause these differences, 
molecular mechanism remains unclear.   
In contrast to our results, aged rats showed significant 
downregulation of ERβ in the hippocampus (Mehra et al., 2005). Middle 
aged rats exhibit the opposite endocrinological status (i.e. high estrogen 
level and low LH level) to perimenopausal macaques (low estrogen level 
and high LH level), though prolonged cycles and gradual cessation of 
estrus of middle aged rats are similar to characteristics in human or 
macaque menopausal transition (Chakraborty and Gore, 2004). In aged 
rats, high estrogen level from ovary may bring about the decrease of ERβ 
expression in the hippocampus. Thus, in both aged monkeys and rats, ERβ 
expression in the hippocampus seems to keep homeostasis in response to 
age-related changes in the level of ovary-derived estrogen. 
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It has been reported that postmortem brains developing AD showed 
apparent upregulation of ERβ in the CA1-4 regions of the hippocampus 
compared to age-matched control patients (Savaskan et al., 2001). The 
upregulation of ERβ in the hippocampus of AD patients and our 
menopausal monkeys may be induced to enhance the neuroprotective effect 
of estrogen. In the hippocampus of healthy menopausal women, aromatase 
immunoreactivity were upregulated (Ishunina et al., 2007), which is 
similar to our finding in the hippocampus of ovariectomized monkeys 
rather than that of menopausal monkeys. Similarity in the response of 
aromatase against estrogen depletion between healthy menopausal 
humans and ovariectomized premenopausal monkeys is consistent with a 
hypothesis that healthy aging of the brain is one of the features of brain 
evolution in hominids (Allen et al., 2005). We assume that adequate level of 
estrogen actively supplied with aromatase in the hippocampus may be 
crucial for the aged women to keep brains healthy for the longest life 
expectancy. 
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Fig.1. Representative hormonal profiles of premenopausal (pre), 
ovariectomized (ovx), and perimenopausal (peri) monkeys from September 
to January. Solid vertical bars indicate the first day of menstruation, and 
an arrow indicates the day of ovariectomy. The hormonal profile of the ovx 
monkey after the operation was similar to that of the perimenopausal 
monkey. Filled circles: estradiol, open circles: progesterone, gray squares: 
luteinizing hormone (LH).   
 
Fig. 2. ERβ-immunoreactivity (ir; a, c, e) and Aromatase (Arom)-ir (b, d, f) 
in the hippocampal formation. Membranous ERβ-ir was observed in 
fusiform and multipolar interneurons in the subiculum (Sub; c) and in the 
stratum oriens of CA1 (e) of the hippocampus.. Aromatase (Arom)-ir was 
also observed in the Sub (d) and CA1 (f). ERβ-ir and Arom-ir were present 
in the hippocampus of all the examined groups. Bars = 500 μm (a, b) and 50 
μm (c-f), respectively.  
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Fig. 3. Colocalization of ERβ and calcium binding proteins in single cells 
are confirmed with z-projection of the confocal image stacks. Nearly all of 
ERβ (green) was colocalized with parvalbumin (PV, red) in the subiculum 
(a, b). Double-immunofluorescence for ERβ (green) and calretinin (CR, red 
in c) or calbindin (CB, red in d) in the subiculum failed to demonstrate 
colocalization. Bars = 20 μm (a, c, d), 50 μm (b) 
 
Fig.4. Integrated optical density (IOD) for semi-quantified ERβ (a) and 
Arom (b)- ir in the subiculum of ovariectomized (ovx), perimenopausal 
(peri) and postmenopausal (post) monkeys is represented as the ratio to 
that of premenopausal (pre) monkeys. Note the ERβ-ir was prominently 
elevated in peri and post monkeys, and Arom-ir was elevated in ovx 
monkeys compared with pre monkeys. Each column indicates an index ± 
standard error. Bars with different superscripts differ significantly (a : b, p 
< 0.05). Photographs are representative clipped images used for the image 
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